πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 72 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 10888558

Regimens of tafenoquine for prevention of malaria in malaria-naive subjects

The Government of the United States, as represented by the Secretary of the Army Β· Granted Tue Jan 12 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 07 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10786435

Composition for optical three-dimensional modeling

KURARAY NORITAKE DENTAL INC. Β· Granted Tue Sep 29 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 24 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10517491

Cardiac phase-resolved non-breath-hold 3-dimensional magnetic resonance angiography

The Regents of the University of California Β· Granted Tue Dec 31 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10428157

Dosing regimens for use with PCSK9 inhibitors

REGENERON PHARMACEUTICALS, INC. Β· Granted Tue Oct 01 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10350256

Compositions for the treatment of dermatological conditions, disorders or diseases

Veit Hoermann Gesellschaft FΓΌr Unternehmenskommunikation mbH Β· Granted Tue Jul 16 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10342791

Regimens of tafenoquine for prevention of malaria in malaria-naive subjects

The United States of America as represented by the Secretary of the Army Β· Granted Tue Jul 09 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 04 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10335460

IL-15 and IL-15RΞ± heterodimer dose escalation regimens for treating conditions

THE UNITED STATES OF AMERICA, DEPARTMENT OF HEALTH AND HUMAN SERVICES Β· Granted Tue Jul 02 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 27 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10093790

Three-dimensional cellulose molded body, method for the production thereof and use of the

LENZING AKTIENGESELLSCHAFT Β· Granted Tue Oct 09 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 04 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10016461

Apparatus and process for growing a heart valve in three-dimensions

The Regents of the University of California Β· Granted Tue Jul 10 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9976123

Cellular seeding and co-culture of a three dimensional fibroblast construct

Arizona Board of Regents on Behalf of the University of Arizona Β· Granted Tue May 22 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 17 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9675655

Compositions for the treatment of dermatological conditions, disorders or diseases

Veit Hoermann Gesellschaft FΓΌr Unternehmenskommunikation mbH Β· Granted Tue Jun 13 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 08 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9592255

Scaffold-free three dimensional nerve fibroblast constructs

THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Tue Mar 14 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9498468

Rhinitis treatment regimens

Pharmaceutical Design, LLC Β· Granted Tue Nov 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9051550

Cellular seeding and co-culture of a three dimensional fibroblast construct

Arizona Board of Regents on Behalf of the University of Arizona Β· Granted Tue Jun 09 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 04 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8858945

Three-dimensional structure of complement receptor type 2 and uses thereof

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Oct 14 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 09 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8741589

Monitoring two dimensions of diabetes pathogenesis

The Regents of the University of California Β· Granted Tue Jun 03 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 29 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8734825

Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of bo

Covidien LP Β· Granted Tue May 27 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 22 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8680084

Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology

TEVA WOMEN'S HEALTH, INC. Β· Granted Tue Mar 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8673332

Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of bo

Covidien LP Β· Granted Tue Mar 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8563023

Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of bo

Covidien LP Β· Granted Tue Oct 22 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8465737

Three-dimensional structure of complement receptor type 2 and uses thereof

The Regents of the University of Colorado Β· Granted Tue Jun 18 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 13 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8450299

Methods of hormonal treatment utilizing ascending-dose extended cycle regimens

Teva Womans's Health, Inc. Β· Granted Tue May 28 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 23 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8415332

Methods of hormonal treatment utilizing ascending-dose extended cycle regimens

Teva Womans's Health, Inc. Β· Granted Tue Apr 09 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 04 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8349586

Commensal strain of E. coli encoding an HIV GP41 protein

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jan 08 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 03 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted